NeoModulus Honored with Dual Accolades: Named to 2024 Top 100 Innovative Emerging Enterprises and High-Value Consumables Innovation Index in China's Medical Device Industry

Dec 14, 2024 11:48 CST Updated 11:48

Neo Modulus

Developer of Human Tissue Repair and Organ Regeneration Products

In order to effectively strengthen the radiating and leading role of national-level innovation platforms, deeply activate innovation momentum, and accelerate the development of new quality productivity in China's medical equipment industry, the National Innovation Center for High-Performance Medical Devices has released“2024Annual Medical Device Industry Innovation Ecosystem Insight Assessment”。After multiple rounds of strict screening,Neo Modulus in this assessmentStand out, SuccessAwarded Dual Honors: "Top 100 Emerging Companies in the 2024 Medical Device Industry Innovation Index" and "Innovation Index in the High-Value Consumables Field of the 2024 Medical Device Industry", which is also the second consecutive year that Neo Modulus has been rated as the annualTop 100 Emerging Companies Innovation Index in the Medical Device Industry。

This series of rankings and awards aims to discover new forces in China's medical device industry, highlight excellent achievements in innovative medical devices, promote the rapid growth of emerging medical device companies, and help build an innovation ecosystem for medical devices.

Neo Modulus Selected“2024 Medical Device Industry Top 100 Emerging Companies Innovation Index”, showcasing its emerging presence,Brings Breakthrough Technologies and Solutions to the Medical Device Field, injecting new vitality into the industry. Meanwhile, selected for inclusion“2024 Medical Device Industry High-Value Consumables Field Innovation Index” The list highlights Neo Modulus's outstanding achievements in corporate value creation and industry-university-research cooperation innovation, particularly making significant contributions in technological innovation and market application in the fields of regenerative medicine and tissue engineering.

As an innovative enterprise focusing on regenerative implant medical devices, Neo Modulus actively responds to China's national strategic guidance and adheres to the development philosophy of innovation and internationalization.Currently, the company's independently developedIIIClass Medical Devices“Neo®Gelatin-Polycaprolactone Layered Gingival Repair Membrane”“Rui Wen®Oral Repair Membrane”“Wenmai®Dental Bone Grafting Material”AndIIClass Medical Devices“Oleyoo®Expansive Hemostatic Sponge”“Pin Yu®Medical Adhesive”Products such as have been approved for marketing, among which“Neo®Gingival Repair Membrane”Is the first domestically approvedIIIClass of Non-Powered Implantable National Innovative Dental Instruments,“Ole Yuh®Expansive Hemostatic Sponge”Has already been obtainedMDR CECertification, gradually emerging in the global market and gaining widespread attention。

Neo Modulus is steadily advancing the research and development and clinical trials of a series of innovative products, covering multiple cutting-edge disciplines such as dentistry, ophthalmology, reproductive medicine, and sports medicine. This demonstrates the company's strong R&D capabilities and broad development prospects. Looking ahead, Neo Modulus will continue to tirelessly focus on regenerative medicine and tissue engineering, shouldering the responsibility of a Chinese enterprise to continuously provide innovative and high-quality medical solutions. It aims to contribute wisdom and strength to promoting China’s new quality productive forces onto the global stage.

Statement:

This article is for news purposes only, and its content is solely intended for information dissemination or industry exchange.The content should not be regarded as an advertisement or representing any express or implied advertising, nor should it be considered to contain any purpose of sales or promise of sales.For accurate information, please consult a professional medical institution and seek expert advice.

If any individual or media, website wants to reprint this article, please contact the official account for authorization and indicate the source of the reprint.